Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology

By Touchon Jacques   Bergman Howard   Bullock Roger   Rapatz Günter   Nagel Jennifer   Lane Roger  

Current Medical Research and Opinion, Vol. 22, Iss. 1, 2006-01 ,pp. : 49-59

Informa Healthcare

Access to resources Recommend Favorite

Location of white matter changes and response to donepezil in patients with Alzheimer's disease: A retrospective and observational study

By  

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 18, Iss. 1, 2018-01 ,pp. : 123-129

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period

By Bullock Roger   Touchon Jacques   Bergman Howard   Gambina Giuseppe   He Yunsheng   Rapatz Günter   Nagel Jennifer   Lane Roger  

Current Medical Research and Opinion, Vol. 21, Iss. 8, 2005-08 ,pp. : 1317-1328

Informa Healthcare

Access to resources Recommend Favorite

Effect of donepezil in patients with Alzheimer's disease previously untreated or treated with memantine or nootropic agents in Germany: an observational study

By Klinger Tatjana   Ibach Bernd   Schoenknecht Peter   Kamleiter Martin   Silver Gabrielle   Schroeder Johannes   Mielke Ruediger  

Current Medical Research and Opinion, Vol. 21, Iss. 5, 2005-05 ,pp. : 723-732

Informa Healthcare

Access to resources Recommend Favorite

Donepezil in Alzheimer's disease: a clinical observational study evaluating individual treatment response

By Riepe Matthias W.   Kohler Jürgen   Horn Rolf  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1829-1835

Informa Healthcare

Access to resources Recommend Favorite